Intellipharmaceutics International Inc. (IPCI)

[AngeloFoca]

AngeloFoca, Glucophage_XR not partnered with Mallinckrodt

ohhoops mia colpa, mia colpa, mia massima colpa.

Thanxs for keeping me honest Numbers.

Whatever the specifics are... the way I broad brush reason is:

If there are 18 manufacturers... then all things considered equal, IPCI/Partner should capture ~ 5% of the market when matured... which might be 3 years time.

But it certainly could start with a .1% of the market and gain .1% on a monthly basis thereafter to arrive at 1% by years end.

We/re talking generics... so not a whole lot of marketing savvy nor expense required... it's primarily cultivating the relationship the partner has with the chain buyer.

If IPCI's partner has a ton of airline tickets to Scotland and membership at a prestigious golf course... we're set!!!

I think Generics are more like a commodity than a branded product, much the same as apples and oranges are... does anyone really ask where do they come from, who makes them???

I would not worry about IPCI's production capacity other than a few millions $ that may be required for expansion.